The adorable Milo was in today to see our internal medicine team for his first Melanoma Vaccine
Studies have shown that this vaccine is effective in prolonging survival times of patients diagnosed with malignant melanomas. The vaccine is given into a hindlimb and tends to be really well tolerated. Side-effects are very uncommon. Milo was such a brave boy but appreciated lots of cuddles from VCA Katie and RVN Kate 








